HomeHealth articleshypothermiaHow Is ECMO Used for Severe Hypothermia in Adults?

ECMO for Severe Hypothermia in Adults

Verified dataVerified data
0

4 min read

Share

Extracorporeal membrane oxygenation is used to rescue patients affected by severe hypothermia by supporting heart and lung function.

Written by

Dr. Monisha. G

Medically reviewed by

Dr. Basuki Nath Bhagat

Published At April 20, 2023
Reviewed AtAugust 25, 2023

Introduction:

Extracorporeal membrane oxygenation (ECMO) is a life support procedure performed to help patients with oxygenation of blood and breathing when the patient is unable to perform the function due to some abnormality or medical condition affecting the heart and the lungs simultaneously.

What Is ECMO?

ECMO means extracorporeal membrane oxygenation. It is a device similar to the heart-lung bypass machine used during open-heart surgery. It takes over the functions of the heart and the lungs and works for them. It pumps and purifies the blood outside the patient’s body. This allows the heart and lungs to rest. In simple words, ECMO receives your deoxygenated blood from the body, and after receiving it oxygenates the blood and removes carbon dioxide, increases the temperature of blood similar to body temperature, and pumps that blood back to the body. There are two types of ECMO and they are:

  1. VA ECMO (Veno-Arterial Extracorporeal Membrane Oxygenation): This ECMO is connected to both vein and an artery. It is used when both heart and lung functions are compromised.

  2. VV ECMO (Veno-Venous Extracorporeal Membrane Oxygenation): An ECMO connected to one or more veins, located near the heart is called VV ECMO. It is used when the lungs do not functioning properly.

What Are the Indications of ECMO?

  • Used as a supportive aid for patients recovering from post-cardiac or pulmonary failure.

  • Used to assess other organs like the brain, kidneys, and liver before undergoing heart or lung surgery

  • Used as an adjuvant during procedures that carry a high risk of cardiac failure such as cardiac catheterization lab (invasive procedure performed to assess blood flow to the heart from the arteries).

  • Used as a bridging support to devices assisting heart function, like left ventricular device (LVAD).

  • Used to maintain the vitality and oxygenation of the tissues in patients awaiting lung transplantation, making them better recipients.

How Is an ECMO Performed?

ECMO is performed in three stages involving the insertion of catheter or cannulas, maintenance of ECMO, and termination of the procedure.

1. Insertion:

  • The procedure is done in the patient's room, an operation theatre is not required.

  • The patient is given anesthesia, painkillers, and anti-coagulants to prevent blood from clotting.

  • ECMO catheter (thin tube) is inserted into an artery or vein by a trained surgeon.

  • The placement of the catheter is confirmed with an X-ray.

2. Maintenance:

  • While the patient is on ECMO, the vital signs and breathing is continuously monitored by a surgeon, nurses, and respiratory therapists.

  • The ventilator is also connected to the ECMO to allow the patient’s lungs to rest and heal.

  • Nutrition is supplemented through a nasogastric tube or intravenously since the patient is under sedation and will have a breathing tube through the mouth.

  • ECMO catheters are used to administer medications like heparin to control blood clots, antibiotics to avoid infection, painkillers, diuretics to improve kidney function, sedatives to prevent bodily movements and induce sleep, and electrolytes to maintain the salt and sugar balance.

3. Termination:

  • It is the step where ECMO is removed from the body. But, before removal, the functioning of the heart and the lungs is checked.

  • Confirmatory tests are done to assess whether the organs are ready to function on their own.

  • After ECMO catheters are removed, the vessel through which the tubes were inserted are repaired with stitches.

What Are the Advantages of ECMO?

  • ECMO is a life-saving device for critically ill patients in intensive care units.

  • It takes the workload of the heart and lungs, allowing the organs to recover.

  • Makes it possible to keep a patient alive during surgical procedures.

  • Gives circulatory and ventilatory support for transplant patients until they receive the donor organs.

  • Supports babies' hearts and lungs that are underdeveloped.

What Is Hypothermia?

Hypothermia is the condition in which the body’s temperature gets reduced below 35 degrees Celsius. It occurs when the body is exposed to very cold temperatures for a long period. On exposure to cold temperatures, the body starts to lose heat rapidly whereas heat production is slow. It will eventually lead to loss of stored energy which drops the core body temperature. It is a dangerous medical condition because low body temperature affects the central nervous system and the patient is in a confused state.

Who Are at Risk of Hypothermia?

The following group of people is at increased risk of getting hypothermic:

  • Elderly with a lack of adequate nutrition, protective clothing, and heat.

  • Babies and infants sleeping in cold environments.

  • Individuals who stay outdoors for a long time - the homeless, hunters, and workers.

  • People who take illegal drugs and consume alcohol.

What Are the Signs and Symptoms of Hypothermia?

The followings are the signs and symptoms of hypothermia in adults and children-

1. Adults:

  • Fatigue.

  • Confusion.

  • Dizziness.

  • Slurred speech.

  • Shivering.

  • Loss of memory.

  • Clumsy hand and feet movements.

2. Children:

  • Cold skin.

  • Bright red discolored skin.

  • Tiredness.

How Is ECMO Used for Hypothermia in Adults?

  • Rewarming severely hypothermic patients using ECMO is the choice of treatment for patients with hypothermic cardiac arrest and instability. It provides a stable, gradual, and controlled increase in body temperature, along with circulatory and respiratory support during the recovery period from hypothermia.

  • The ECMO procedure remains the same for hypothermia except for a few differences in the vascular access and maintenance of blood flow. Hypothermia required rapid fluid resuscitation and a slight change in the procedure.

  • The ideal blood flow and re-warming rate are yet to be studied and standardized.

  • Advances cannulas are developed for ready-to-use ECMO devices to shorten the time needed for resuscitation.

  • The ECMO type most preferred is VA-ECMO due to its easy availability, minimal anticoagulant requirement, and longer support time.

  • It is indicated in stage 3 hypothermia (20-28 ℃) presenting with unconsciousness and stage 4 hypothermia (less than 20 ℃) with no vital signs.

  • The maximum rewarming rate is up to 6℃ per hour given over a wide range of time.

  • Cardiac output decreases with slow ECMO post-treatment but does not cause lung lesions.

  • The patient with cardiac arrest should be first moved from the cold environment.

  • For ECMO, vessel access is taken through the femoral vein and artery(which develop the complication of leg ischemia) using distal perfusion cannulas. Ultrasound-guided venous and arterial access is also done.

  • Research is being done to develop cannulas that enable parallel and bidirectional flow for blood perfusion to the extremities.

  • Challenges faced by a severely hypothermic patient are depletion of body fluid and the immediate need for aggressive fluid replacement. It is essential to maintain the blood flow through ECMO.

  • Tissue edema and compartment syndrome are other complications that develop in hypothermia posing a challenge for ECMO procedure.

Conclusion:

At present, there is no standardized protocol for ECMO while treating a severely hypothermic patient. New cannulas with advanced features and simplified ECMO kits which are ready to use are under research. Studies are ongoing to reduce the need for heparin will potentially shorten the resuscitation time. Even though ECMO is beneficial in rewarming hypothermic patients, it has its own risks and complications, which should be addressed by trained and skilled clinicians in the emergency department.

Frequently Asked Questions

1.

Which Vascular Access Is Typically Utilized for ECMO?

For extracorporeal membrane oxygenation (ECMO), the preferred vascular access is often achieved through large-bore cannulas placed in the major vessels. Typically, the common approach involves using a dual-lumen venovenous ECMO (VV-ECMO) configuration, where the cannulas are inserted into the internal jugular vein or the femoral vein for venous drainage and reinfusion, respectively.

2.

What Sets Venovenous ECMO Apart from Venoarterial ECMO?

Venovenous ECMO (VV-ECMO) primarily supports the function of the lungs by removing deoxygenated blood, oxygenating it, and returning it to the patient's venous system. In contrast, venoarterial ECMO (VA-ECMO) provides both cardiac and respiratory support, as it removes deoxygenated blood from the venous system and returns oxygenated blood to the arterial system, effectively assisting both the heart and lungs.

3.

What Is the Primary Objective of ECMO?

The primary objective of ECMO (extracorporeal membrane oxygenation) is to provide temporary life support for patients with severe respiratory or cardiac failure. It aims to supplement or replace the function of the heart and lungs, allowing time for the patient's native organs to recover.

4.

Could One Explain the Operational Mechanism of ECMO?

Extracorporeal Membrane Oxygenation (ECMO) is a life support technique used for patients with severe respiratory or cardiac failure. It involves removing blood from the patient's body, passing it through an artificial membrane oxygenator to oxygenate and remove carbon dioxide, and then returning the oxygenated blood to the patient.

5.

Which Specific Vein Is Commonly Accessed in ECMO Procedures?

The femoral vein is commonly accessed in ECMO procedures due to its large size and accessibility. Additionally, it offers a lower risk of complications compared to other sites, making it the preferred choice for initiating ECMO support.

6.

How Does ECPR Differ from ECMO in Terms of Its Purpose and Application?

While ECMO provides circulatory and respiratory support, ECPR (Extracorporeal Cardiopulmonary Resuscitation) is specifically used during cardiac arrest to temporarily replace heart and lung function.

7.

What Stands Out as the Most Prevalent Complication Associated with ECMO?

Hemorrhage or bleeding is one of the most common complications associated with ECMO. This risk arises from the need for anticoagulation to prevent blood clot formation within the ECMO circuit, which can lead to bleeding complications at the cannulation sites or elsewhere in the body.

8.

What Is the Risk of Bleeding Associated with ECMO Therapy?

The use of ECMO therapy can potentially lead to an increased risk of bleeding due to the need for anticoagulation to prevent blood clot formation within the ECMO circuit. This anticoagulation can predispose patients to hemorrhagic complications, which may manifest as bleeding at the cannula insertion sites, gastrointestinal bleeding, or other sites.

9.

Is There a Potential for ECMO to Lead to Kidney Damage?

Yes, ECMO can potentially contribute to kidney damage due to factors such as reduced blood flow to the kidneys and the effects of systemic inflammation. Additionally, the use of certain medications and the need for continuous monitoring and adjustment of fluid status during ECMO therapy can impact renal function.

10.

Can ECMO Be a Catalyst for Sepsis in Patients Undergoing the Treatment?

Yes, ECMO can potentially increase the risk of sepsis due to the introduction of foreign materials, such as cannulas, into the bloodstream, which may serve as sites for bacterial colonization and subsequent infection. Additionally, the immunosuppressive effects of ECMO and the underlying critical illness can further compromise the patient's ability to combat infections, leading to an increased susceptibility to sepsis.

11.

What Are the Common Infectious Risks After Undergoing ECMO Therapy?

Common infectious risks after undergoing ECMO therapy include bloodstream infections, pneumonia, surgical site infections, and catheter-related infections. These complications can arise due to the introduction of foreign materials, prolonged hospital stays, compromised immunity, and the use of broad-spectrum antibiotics, which may lead to the development of resistant organisms.

12.

In What Medical Scenarios Is ECMO Considered a Contraindication?

ECMO is considered a contraindication in certain medical scenarios, including irreversible neurological injury, terminal illness with no possibility of recovery, and certain severe comorbidities that significantly limit the patient's overall life expectancy and quality of life.

13.

What Effects Does ECMO Have on the Pulmonary System During Treatment?

During ECMO treatment, the pulmonary system experiences reduced physiological workload as the ECMO circuit assumes the function of oxygenation and carbon dioxide removal. This reduced workload allows the lungs to rest and heal, which can be particularly beneficial in cases of severe respiratory failure.

14.

Do the Lungs Have the Capacity to Recover Following ECMO Therapy?

Yes, the lungs can recover following ECMO therapy, especially when used in cases of reversible lung injury or acute respiratory failure. By providing temporary support and allowing the lungs to rest and heal, ECMO can help reduce the severity of lung damage and promote the recovery of lung function.

15.

What Are the Contraindications for Implementing ECMO in Patients with Acute Respiratory Distress Syndrome (ARDS)?

Contraindications for implementing ECMO in patients with acute respiratory distress syndrome (ARDS) include irreversible end-organ failure, advanced age with significant comorbidities, severe and irreversible brain injury, uncontrolled bleeding, and terminal illness with no potential for meaningful recovery.

16.

When Is ECMO Most Appropriately Indicated as a Medical Intervention?

ECMO is most appropriately indicated as a medical intervention in critical situations of cardiac or respiratory failure where other treatments have proven ineffective or when there is a reversible cause for the failure.
Source Article IclonSourcesSource Article Arrow
Dr. Basuki Nath Bhagat
Dr. Basuki Nath Bhagat

Family Physician

Tags:

extracorporeal membrane oxygenation (ecmo)hypothermia
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

hypothermia

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy